logo

For the Inventor, By the Inventor

Sunnyvale, CA, United States of America

Stephen Willingham

LinkedIn
USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Stanford, CA (US) (2017 - 2018)
  • Sammamish, WA (US) (2022)
  • Sunnyvale, CA (US) (2019 - 2024)
  • Mountain View, CA (US) (2021 - 2024)

Company Filing History:

goldMedal13 out of 5,309 
 
Leland Stanford Junior University
 patents
silverMedal5 out of 15 
 
Corvus Pharmaceuticals, Inc.
 patents

Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 12258403 - Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody (2025-03-25),
2. 12258399 - Methods for achieving therapeutically effective doses of anti-CD47 agents (2025-03-25),
3. 12174192 - Methods for detecting and treating cancers having adenosine pathway activation (2024-12-24),
4. 12116635 - Methods for detecting and treating cancers having adenosine pathway activation (2024-10-15),
5. 12037402 - Treatment of cancer with dual targeting of CD47 and EGFR (2024-07-16),
6. 12023337 - Methods of treating cancer (2024-07-02),
7. 11603404 - Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody (2023-03-14),
8. 11518806 - Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody (2022-12-06),
9. 11154600 - Use of anti-CD47 agents to enhance immunization (2021-10-26),
10. 11136391 - Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody (2021-10-05),
11. 11130813 - Treatment of cancer with dual targeting of CD47 and EGFR (2021-09-28),
12. 11104731 - Compositions for achieving therapeutically effective doses of anti-CD47 agents (2021-08-31),
13. 11040040 - Methods of treating cancer (2021-06-22),
14. 10912776 - Methods of treating cancer (2021-02-09),
15. 10344094 - Treatment of cancer with dual targeting of CD47 and EGFR (2019-07-09),

Title: The Inventor Stephen Willingham: Pioneering Innovations in Sunnyvale

Introduction: Stephen Willingham is a renowned inventor based in Sunnyvale, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Stephen Willingham holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the tech industry, Stephen Willingham has worked for leading companies such as Google X and Tesla, where he played a key role in developing cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Stephen Willingham has collaborated with top researchers, engineers, and scientists from prestigious universities and research institutions worldwide, fostering a culture of innovation and excellence in all his projects.

Conclusion: Stephen Willingham's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs in Sunnyvale and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…